Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | CTSB | P07858 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.34 |
| ▸ | GLP1R | P43220 | 8/20 | 0.33 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.33 |
| ▸ | FURIN | P09958 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TLR2 | O60603 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25520149 | 0.92 | GLP1R (0.40) | CTSLCTSBGLP1R | |
| SCHEMBL24629772 | 0.92 | GLP1R (0.40) | CTSLCTSBGLP1R | |
| SCHEMBL29727728 | 0.90 | GLP1R (0.41) | GLP1RTLR2 | |
| SCHEMBL24629756 | 0.90 | GLP1R (0.41) | GLP1RTLR2 | |
| SCHEMBL24630314 | 0.90 | GLP1R (0.44) | GLP1RTLR2 | |
| SCHEMBL29336004 | 0.89 | GLP1R (0.42) | GLP1RTLR2 | |
| SCHEMBL29332671 | 0.88 | NMT1 (0.42) | GLP1RTLR2 | |
| SCHEMBL25517106 | 0.88 | GLP1R (0.37) | GLP1R | |
| SCHEMBL25521723 | 0.86 | GLP1R (0.47) | GLP1RTLR2 | |
| SCHEMBL25978500 | 0.85 | GLP1R (0.49) | GLP1RTLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4651901-A1 | CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES | Lycia Therapeutics, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |